IE66739B1 - Therapeutic system for the retarded and controlled transdermal or transmucous administration of active substances (II) - Google Patents

Therapeutic system for the retarded and controlled transdermal or transmucous administration of active substances (II)

Info

Publication number
IE66739B1
IE66739B1 IE58090A IE58090A IE66739B1 IE 66739 B1 IE66739 B1 IE 66739B1 IE 58090 A IE58090 A IE 58090A IE 58090 A IE58090 A IE 58090A IE 66739 B1 IE66739 B1 IE 66739B1
Authority
IE
Ireland
Prior art keywords
active substance
therapeutic system
reservoir
auxiliary agent
active
Prior art date
Application number
IE58090A
Other languages
English (en)
Other versions
IE900580L (en
Inventor
Walter Muller
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of IE900580L publication Critical patent/IE900580L/xx
Publication of IE66739B1 publication Critical patent/IE66739B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Furan Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Steroid Compounds (AREA)
IE58090A 1989-02-18 1990-02-16 Therapeutic system for the retarded and controlled transdermal or transmucous administration of active substances (II) IE66739B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3905050A DE3905050A1 (de) 1989-02-18 1989-02-18 Therapeutisches system zur verzoegerten und gesteuerten transdermalen oder transmucosalen verabreichung von wirkstoffen (ii)

Publications (2)

Publication Number Publication Date
IE900580L IE900580L (en) 1990-08-18
IE66739B1 true IE66739B1 (en) 1996-02-07

Family

ID=6374442

Family Applications (1)

Application Number Title Priority Date Filing Date
IE58090A IE66739B1 (en) 1989-02-18 1990-02-16 Therapeutic system for the retarded and controlled transdermal or transmucous administration of active substances (II)

Country Status (15)

Country Link
US (1) US5466466A (enExample)
EP (1) EP0384266B1 (enExample)
JP (1) JP2552190B2 (enExample)
AT (1) ATE108680T1 (enExample)
AU (1) AU627268B2 (enExample)
CA (1) CA2010218C (enExample)
DD (1) DD291928A5 (enExample)
DE (2) DE3905050A1 (enExample)
DK (1) DK0384266T3 (enExample)
ES (1) ES2060825T3 (enExample)
FI (1) FI105157B (enExample)
IE (1) IE66739B1 (enExample)
NO (1) NO303207B1 (enExample)
PT (1) PT93191B (enExample)
ZA (1) ZA901183B (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT65957A (en) † 1992-03-17 1994-08-29 Becton Dickinson Co User operated iontophoretical device and method for manufacturing it
US5730721A (en) 1996-01-25 1998-03-24 Vesture Corporation Medical applicator and method
DE19653606A1 (de) * 1996-12-20 1998-06-25 Roehm Gmbh Haft- und Bindemittel aus (Meth)acrylatpolymer, organischer Säure und Weichmacher
US5912255A (en) * 1998-02-27 1999-06-15 Bussell; Letantia Topical fluoroquinolone antibiotics combined with benzoyl peroxide
DE19814083C2 (de) 1998-03-30 2002-02-07 Lohmann Therapie Syst Lts Verfahren zur Herstellung von transdermalen therapeutischen Systemen unter Verwendung von basischen Alkalimetallsalzen zur Umwandlung von Wirkstoffsalzen in die freien Basen
DE19814087A1 (de) * 1998-03-30 1999-10-14 Lohmann Therapie Syst Lts Feuchtigkeitsaktivierbares therapeutisches System
US6416777B1 (en) * 1999-10-21 2002-07-09 Alcon Universal Ltd. Ophthalmic drug delivery device
US7943162B2 (en) * 1999-10-21 2011-05-17 Alcon, Inc. Drug delivery device
CA2383499C (en) 1999-10-21 2009-11-24 Alcon Universal Ltd. Drug delivery device
CA2383572C (en) 1999-10-21 2007-12-11 Alcon Universal Ltd. Sub-tenon drug delivery
US20060189552A1 (en) * 2000-12-12 2006-08-24 Mohan Vishnupad Dispenser for dispensing three or more actives
US20020193321A1 (en) * 2000-12-12 2002-12-19 Mohan Vishnupad Dual dispenser for aesthitically acceptable delivery of anhydrous skin treatment compositions
US7060732B2 (en) * 2000-12-12 2006-06-13 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
US7563255B2 (en) 2001-05-03 2009-07-21 Massachusetts Eye And Ear Infirmary Implantable drug delivery device and use thereof
MXPA03011609A (es) 2001-07-23 2004-07-01 Alcon Inc Dispositivo de entrega de droga oftalmica.
CN100349562C (zh) * 2001-07-23 2007-11-21 爱尔康公司 眼部药物输送装置
BRPI0410542A (pt) * 2003-07-10 2006-06-20 Alcon Inc dispositivo de administração de medicamento para um olho e método de administrar um agente farmaceuticamente ativo a um olho
WO2005042055A2 (en) * 2003-10-28 2005-05-12 Noven Pharmaceuticals, Inc. Transdermal drug delivery device
US20060014834A1 (en) * 2004-05-11 2006-01-19 Mohan Vishnupad Retinoid solutions and formulations made therefrom
US7662855B2 (en) * 2004-05-11 2010-02-16 Imaginative Research Associates, Inc. Retinoid solutions and formulations made therefrom
DE102004062614B4 (de) * 2004-12-24 2011-12-29 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit aktivierbarer Übersättigung und kontrollierter Permeationförderung sowie Verfahren zu dessen Herstellung
US20080138388A1 (en) * 2005-02-04 2008-06-12 Hisamitsu Pharmaceutical Co., Inc. Transdermal Absorption Patch
CA2616537A1 (en) 2005-07-27 2007-02-01 University Of Florida Research Foundation, Inc. Small compounds that correct protein misfolding and uses thereof
JP5180834B2 (ja) 2005-11-29 2013-04-10 スミスクライン ビーチャム コーポレーション 治療方法
TWI451862B (zh) * 2007-10-09 2014-09-11 Alcon Res Ltd 用於眼睛注射的熱係數驅動藥丸尺寸
TWI498136B (zh) * 2007-10-09 2015-09-01 Alcon Res Ltd 用於遞送速率及溫度相依性物質至眼睛的注射器及其製備方法
DE102008013701A1 (de) * 2008-03-11 2009-09-17 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System mit stabilisierter Membran
US8632511B2 (en) 2009-05-06 2014-01-21 Alcon Research, Ltd. Multiple thermal sensors in a multiple processor environment for temperature control in a drug delivery device
IN2012DN00352A (enExample) 2009-06-16 2015-08-21 Bikam Pharmaceuticals Inc
WO2011039648A1 (en) 2009-09-30 2011-04-07 Glaxo Wellcome Manufacturing Pte Ltd. Methods of administration and treatment
US8177747B2 (en) 2009-12-22 2012-05-15 Alcon Research, Ltd. Method and apparatus for drug delivery
CA2833474C (en) 2011-04-18 2017-09-19 Hisamitsu Pharmaceutical Co., Inc. Method for producing patch, and patch
EA026121B1 (ru) 2011-06-14 2017-03-31 Бикам Фармасьютикалз, Инк. Опсин-связывающие лиганды, композиции и способы их использования
EP2768307B1 (en) 2011-10-19 2020-03-18 Bikam Pharmaceuticals, Inc. Opsin-binding ligands, compositions and methods of use
AU2012346214B2 (en) 2011-11-30 2017-09-14 Bikam Pharmaceuticals, Inc. Opsin-binding ligands, compositions and methods of use
BR112014013106A2 (pt) 2011-12-01 2017-06-13 Bikam Pharmaceuticals Inc ligantes de ligação à opsina, composições e métodos de uso
JP7676429B2 (ja) 2020-02-26 2025-05-14 ケース ウエスタン リザーブ ユニバーシティ 誤って折り畳まれたタンパク質の眼疾患を治療するための組成物及び方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405616A (en) 1975-06-19 1983-09-20 Nelson Research & Development Company Penetration enhancers for transdermal drug delivery of systemic agents
US4756710A (en) * 1985-04-05 1988-07-12 Merck & Co., Inc. pH-Mediated drug delivery system
ATE71287T1 (de) 1986-06-13 1992-01-15 Alza Corp Aktivierung eines transdermalen drogenabgabesystems durch feuchtigkeit.
EP0249475A3 (en) 1986-06-13 1989-10-11 Alza Corporation Delayed percutaneous delivery
EP0290262A3 (en) * 1987-05-08 1990-12-12 EASTMAN KODAK COMPANY (a New Jersey corporation) Improved nitrate therapy for angina pectoris
US4781924A (en) * 1987-11-09 1988-11-01 Alza Corporation Transdermal drug delivery device

Also Published As

Publication number Publication date
AU627268B2 (en) 1992-08-20
EP0384266A3 (en) 1990-11-22
NO303207B1 (no) 1998-06-15
JP2552190B2 (ja) 1996-11-06
EP0384266A2 (de) 1990-08-29
DE3905050A1 (de) 1990-08-30
CA2010218C (en) 1998-04-28
IE900580L (en) 1990-08-18
FI900740A0 (fi) 1990-02-14
CA2010218A1 (en) 1990-08-18
ATE108680T1 (de) 1994-08-15
NO900748L (no) 1990-08-20
PT93191B (pt) 1998-01-30
ES2060825T3 (es) 1994-12-01
DE3905050C2 (enExample) 1991-08-08
DK0384266T3 (da) 1994-11-21
NO900748D0 (no) 1990-02-16
AU4877090A (en) 1990-08-23
DD291928A5 (de) 1991-07-18
EP0384266B1 (de) 1994-07-20
DE59006461D1 (de) 1994-08-25
US5466466A (en) 1995-11-14
PT93191A (pt) 1990-08-31
JPH03197420A (ja) 1991-08-28
ZA901183B (en) 1990-11-28
FI105157B (fi) 2000-06-30

Similar Documents

Publication Publication Date Title
US5466466A (en) Therapeutic system for the retarded and controlled transdermal or transmucous administration of active substrates II
EP0316065B1 (en) Improved transdermal drug delivery device
US4031894A (en) Bandage for transdermally administering scopolamine to prevent nausea
US4262003A (en) Method and therapeutic system for administering scopolamine transdermally
AU758399B2 (en) Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder
US4938759A (en) Transdermal delivery device having a rate controlling adhesive
US5284660A (en) Delayed onset transdermal delivery device
US5071656A (en) Delayed onset transdermal delivery device
US4837027A (en) Transdermal drug delivery device
US4460372A (en) Percutaneous absorption enhancer dispenser for use in coadministering drug and percutaneous absorption enhancer
CA2780860C (en) Pharmaceutical composition for external use
EP0195643A2 (en) Compositions and device for controlled transdermal penetration of topical and systematic agents
US8017146B2 (en) Transdermal delivery system with two superimposed adhesive layers having different affinities to the active substance comprised
GB2093694A (en) Dosage form for coadministering drug and percutaneous absorption enhancer
JPS62129058A (ja) 生物学的有効剤を脈動経皮投与するための医学的装置
US5215751A (en) Therapeutic system for the retarded and controlled transdermal or transmucous administration of active substances (i)
US4436741A (en) Method for administering scopolamine transdermally
KR960005148B1 (ko) 활성 물질의 국소적 또는 전신적 투여를 위한 약물의 단계 방출형 경피 투여 시스템
SEKI et al. Membrane Permeation-Controlled Transfermal Delivary System Degisn. Influence of Controlling Membrane and Adhesive on Skin Permeation of Isosorbide Dinitrate

Legal Events

Date Code Title Description
MM4A Patent lapsed